Pharmafile Logo
Pharmafocus logo
Advanced Search
Xarelto image

Xarelto gets new EU approval

November 21, 2012
Sales and Marketing AF, Bayer, DVT, Xarelto

Bayer’s oral anticoagulant Xarelto has extended its licence in Europe to treat pulmonary embolism (PE) and prevent recurrent deep vein …

News
03_dorrepaal_karin_dr_01

Almirall appoints first woman to its Board

November 21, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Almirall

Karin Louise Dorrepaal is the first woman to join Almirall’s ten-member Board of directors. Dorrepaal, who is Dutch, has extensive …

Appointment
Pfizer image

Pfizer in cystic fibrosis alliance

November 21, 2012
Research and Development, Sales and Marketing CFFT, CFTR, FDA, Pfizer

Pfizer and Cystic Fibrosis Foundation Therapeutics (CFFT) have signed a six-year pre-clinical deal to find new drugs to treat the …

News
Avastin image

Avastin shows brain cancer benefit

November 20, 2012
Research and Development, Sales and Marketing Cancer, FDA, Merck, Roche, avastin, brain

In a Phase III trial, Roche’s Avastin has helped people with newly-diagnosed glioblastoma (GBM) live longer without their disease worsening. …

News
catalent image

Catalent wields axe at UK plant

November 20, 2012
Manufacturing and Production CTS, Catalent, Swindon

Around 45 staff at Catalent’s pharmaceutical facility in Swindon, UK, are to lose their jobs because of fluctuating demand for …

News

Pharma manufacturing news in brief

November 20, 2012
Manufacturing and Production Alfa Laval, Boehringer, Fujifilm, Health Canada, Novartis

Our latest round-up of manufacturing news includes a facility contract for Alfa Laval, plus updates from Fujifilm, Novartis, Boehringer Ingelheim …

News
barry_cockcroft

Senior appointments at NHS Commissioning Board

November 20, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, CCGs, NHS

The NHS Commissioning Board (NHS CB) has made several national appointments to the Medical Directorate. Barry Cockcroft (currently chief dental …

Appointment

Roquette fined $4.1m for water pollution

November 20, 2012
Manufacturing and Production DoJ, EPA, Roquette

The US unit of French ingredients producer Roquette Freres has been fined $4.1m for failing to control the discharge of …

News

Boehringer licenses high-pressure production technology

November 20, 2012
Manufacturing and Production BaroFold, Boehringer Ingelheim

Boehringer Ingelheim has licensed a new technology from BaroFold which could improve the efficiency of biopharmaceutical production processes. Colorado, US-based …

News
Alex Neil

SMC put under review

November 20, 2012
Sales and Marketing Alex Neil, NICE, SMC, Scotland

The Scottish Medicines Consortium (SMC) has been put under the spotlight in two reviews ordered by Scotland’s health secretary Alex …

News

What can pharma can learn from Steve Jobs?

November 19, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Apple, Steve Jobs, pharma

 “Creativity is just connecting things. When you ask creative people how they did something, they feel a little guilty because …

Feature

Novartis treatments set for approval

November 19, 2012
Sales and Marketing Bexsaro, CHMP, Novartis, exjade

Two Novartis drugs, meningococcal vaccine Bexsero and iron chelation therapy Exjade, have been given positive opinions by the CHMP, with …

News

European nod for Sanofi drugs

November 19, 2012
Research and Development, Sales and Marketing CHMP, Sanofi

Two of Sanofi’s key drugs have cleared the penultimate hurdle to approval in Europe with a recommendation from the CHMP. …

News

Daiichi Sankyo chief executive elected NPC chairman of the Board

November 19, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Daiichi Sankyo

The National Pharmaceutical Council (NPC) has announced that Daiichi Sankyo president and chief executive John Gargiulo has been elected chairman …

Appointment

Implementation of IHW ‘patchy’

November 16, 2012
Sales and Marketing CCGs, IHW, NHS

An NHS initative which is supposed to drive public health forward is in danger of having only a limited impact, …

News
China pharma image

The future is bright – but don’t rely on emerging markets

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, emerging markets, industry, pwC

The pharma industry could be “on the cusp of a golden era” of renewed productivity and earnings – but only …

News

Sanofi appoints Gary Nabel as chief scientific officer

November 16, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Nabel, Sanofi

Sanofi has announced the appointment of Dr Gary Nabel, senior VP, chief scientific officer and deputy to the president for …

Appointment

EFPIA rejects ‘indiscriminate’ transparency

November 16, 2012
Medical Communications, Research and Development, Sales and Marketing EFPIA, Goldacre, transparency, trials

Europe’s pharma trade body has poured tepid water on the idea of open access to clinical trial data, saying that …

News
Orchid image

Orchid exits Chinese joint venture

November 15, 2012
Manufacturing and Production North China pharma corp, Orchid

India’s Orchid Chemicals & Pharmaceuticals has ducked out of a joint venture it set up in China ten years ago …

News
jonas_jeffery_5x7_300dpi_srgb

Jeff Jonas joins Shire’s Leadership Team

November 15, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Jeff Jonas, Shire

Shire has announced that Jeff Jonas has been appointed president of Shire’s Regenerative Medicine (RM) business and will join the …

Appointment
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026